Omnic Ocas 0.4 mg (Tamsulosin) — Product Description

Omnic Ocas is the original Astellas preparation containing tamsulosin hydrochloride 0.4 mg in a controlled-release matrix. The product is supplied as film-coated tablets for oral use and is the reference alpha-blocker in urological practice for male lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH).

• Active ingredient: Tamsulosin hydrochloride 0.4 mg per tablet
• Form: controlled-release (OCAS — Oral Controlled Absorption System) film-coated tablets
• Pack: 30 tablets
• Manufacturer: Astellas

OCAS (Oral Controlled Absorption System) is Astellas' patented delivery platform: the tablet releases tamsulosin gradually and independently of food intake. Practical consequences:

• can be taken with or without food — unlike conventional tamsulosin capsules (which should be taken 30 minutes after the same meal each day);
• stable plasma levels throughout the day — smoother symptom control;
• predictable pharmacokinetics — fewer fluctuation-related side effects.

Tamsulosin selectively blocks alpha-1A adrenergic receptors in the prostate, bladder neck and urethra. These receptors control smooth muscle tone: blocking them relaxes the muscles around the prostate and bladder outlet, improving urine flow and reducing the symptoms of BPH — hesitancy, weak stream, nocturia, incomplete emptying.

The selectivity is the key advantage: alpha-1A receptors are concentrated in the prostate tissue, so blood-pressure effects are minimal compared to non-selective alpha-blockers.

Omnic Ocas is prescribed by urologists for:

• treatment of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia;
• improvement of urine flow and storage symptoms (frequency, nocturia, urgency);
• long-term symptomatic management of BPH.

The medication is prescription-only and used under urologist supervision.

• Standard dose: 1 tablet (0.4 mg) once daily, after the same meal or without food (OCAS allows flexibility);
• Swallow whole — do not chew or crush (controlled-release matrix);
• Effect on flow symptoms develops within the first days; full benefit within 2–4 weeks;
• Long-term therapy — duration is determined by the urologist;
• Missed dose: take as soon as remembered the same day; never take a double dose.

• Original Astellas product — the reference tamsulosin brand;
• OCAS controlled-release technology — food-independent dosing;
• Selective alpha-1A blockade — minimal blood pressure impact;
• Once-daily regimen;
• Suitable for long-term use under medical supervision.

The most commonly reported adverse reactions:

• dizziness (especially at the start of therapy);
• ejaculation disorders (retrograde or decreased — reversible after discontinuation);
• orthostatic hypotension (rare with selective agents);
• nasal congestion.

Caution with concurrent PDE5 inhibitors (sildenafil, tadalafil) and antihypertensives — the physician adjusts combinations. Medical attention should be sought for fainting or severe dizziness.

• Hypersensitivity to tamsulosin or any component;
• Severe liver insufficiency;
• Orthostatic hypotension (history of fainting on standing);
• Concomitant use with strong CYP3A4 inhibitors (ketoconazole, itraconazole) — physician decision.

Patients undergoing cataract or glaucoma surgery must inform the surgeon about tamsulosin use (intraoperative floppy iris syndrome).

FAQ — Frequently Asked Questions

What is the difference between Omnic Ocas and regular Omnic?

Same active ingredient (tamsulosin 0.4 mg), different delivery: OCAS tablets release gradually and can be taken regardless of food; regular Omnic capsules should be taken 30 minutes after the same meal daily. OCAS offers more flexible daily routine and stable levels.

Can I take it without food?

Yes — that's the point of OCAS technology. Conventional tamsulosin requires food-timing; OCAS does not. Take it at whatever time fits your day consistently.

How quickly will urination improve?

Flow improvements often appear within days; full benefit in 2–4 weeks. If symptoms don't improve after a month, the urologist reviews the diagnosis and combination therapy (e.g., adding a 5-AR inhibitor like Avodart).

Can Omnic be combined with Avodart (dutasteride)?

Yes — the alpha-blocker + 5-AR inhibitor combination is a documented standard in moderate-to-severe BPH: Omnic addresses symptoms quickly, Avodart shrinks the prostate long-term. Combination is prescribed and monitored by the urologist.

Is medical consultation necessary?

Yes. Omnic Ocas is a prescription medication. Regular urological review, blood pressure control and eye-surgery notification (IFIS) are standard practice.

Ask a question or inquire about delivery to your country

Telegram

WhatsApp